Vicarious Surgical Enhances CEO and CFO Severance Protections
TipRanks (Mon, 2-Feb 5:11 PM ET)
Vicarious Surgical Advances Toward Design Freeze with Successful In-Vivo Porcine Lab
Business Wire (Mon, 12-Jan 8:30 AM ET)
Vicarious Surgical Announces Strategic Software Execution Partnership to Streamline Operations
Business Wire (Mon, 29-Dec 4:10 PM ET)
Vicarious Surgical Announces Full Year 2026 Cash Burn Guidance
Business Wire (Mon, 15-Dec 8:30 AM ET)
Vicarious Surgical Announces Reduction in 2025 Cash Burn Outlook
Business Wire (Wed, 3-Dec 7:00 AM ET)
Vicarious Surgical to Participate in the Piper Sandler 37th Annual Healthcare Conference
Business Wire (Wed, 19-Nov 4:15 PM ET)
Vicarious Surgical Reports Third Quarter 2025 Financial Results
Business Wire (Wed, 12-Nov 4:15 PM ET)
Vicarious Surgical to Report Third Quarter 2025 Financial Results on November 12, 2025
Business Wire (Thu, 6-Nov 6:13 PM ET)
Market Chameleon (Wed, 8-Oct 6:02 AM ET)
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port. The company has following segment: Research and development, Sales and marketing, General and administrative.
Vicarious Surgical Class A trades on the NYSE stock market under the symbol RBOT.
As of February 5, 2026, RBOT stock price declined to $1.85 with 74,919 million shares trading.
RBOT has a beta of 2.40, meaning it tends to be more sensitive to market movements. RBOT has a correlation of 0.14 to the broad based SPY ETF.
RBOT has a market cap of $13.17 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, RBOT traded as high as $106.65 and as low as $1.81.
The top ETF exchange traded funds that RBOT belongs to (by Net Assets): VTI, VXF, IWC, DFAC, DFAS.
RBOT has underperformed the market in the last year with a price return of -85.5% while the SPY ETF gained +13.8%. RBOT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -60.2% and -23.2%, respectively, while the SPY returned +0.6% and -1.1%, respectively.
RBOT support price is $1.80 and resistance is $2.10 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RBOT shares will trade within this expected range on the day.